Financial Institutions & Fintech

Arne Grimme + 10 other experts

unique expertise for a unique type of client

Financial Institutions are subject to myriad and ever-evolving regulation affecting their products, services, governance, and processes. Therefore, they need lawyers with a deep understanding of the specific challenges and opportunities they face.

With leading experts in their respective fields, our integrated, multidisciplinary practice has an established track record working both alongside, and within, major financial institutions.

We advise on the most important deals in the financial services market and successfully represent major institutions in litigation, arbitration, and mediation proceedings around the globe.

We help existing market players to navigate fintech developments and to adapt to upcoming regulations, and we advise them seamlessly across borders on the most innovative and complex tech-driven projects and financing.

We also frequently work with emerging fintech companies to achieve their business objectives and protect their intellectual property and know-how within the boundaries of a vast, and sometimes daunting, regulatory regime.

Our Financial Institutions Group is also part of the European Financial Institutions Group set up by our Best Friends Network.

Banking, Finance & Debt Capital Markets

Few firms in the Netherlands can match the quality of our people and our leading position across the full range of corporate, asset and project financing, debt restructuring, and debt capital markets. Our integrated Banking, Finance & Debt Capital Markets practice has a multidisciplinary team dedicated to the design, negotiation and documentation of both general corporate finance transactions and complex high-impact finance transactions.

Investment Management

Against a continually changing legal, economic and regulatory backdrop, our Investment Management experts are at the forefront of all new developments across the full fund lifecycle.

Our Investment Management Experts

Insurance

We advise many of the largest internationally operating insurance groups and financial institutions based in the Netherlands (to include the largest healthcare insurer in the Netherlands) on the application of the rules and regulations on the supervision of financial markets. Our clients trust us with significant mergers and acquisitions, regulatory capital-raising transactions, large outsourcing arrangements, global custody and securities lending, and investment management mandates. Clients also recognise our expertise when seeking advice on which complex supervisory rules they are subject to.

Our Insurance Experts

Insights

29 January 2026

Looking ahead: supervisory priorities and themes expected for the financial sector in 2026

In recent months, supervisory authorities in the Netherlands – AFM and DNB –and the EU – ECB, EBA, ESMA and EIOPA – have published their priorities and agendas for 2026. These publications signal the direction of regulatory rulemaking and supervisory focus in the coming year. Against this backdrop, our Financial Markets & Regulation team has identified key trends and developments that will shape the European financial sector in 2026.
27 November 2025

Omnibus proposal on sustainability: EU bodies inch towards final agreement

On 13 November, the European Parliament adopted its final position on the "Omnibus proposal" for a directive concerning certain corporate sustainability reporting and due diligence requirements. This came five months after the Council of the EU confirmed its negotiating position on the proposal.
30 June 2025

DOJ provides guidance on shift in US white-collar enforcement strategy

As discussed in our February update, the Trump administration started its second term by announcing significant changes in the white-collar enforcement priorities of the U.S. Department of Justice (DOJ). A brief recap: President Trump ordered the DOJ to pause Foreign Corrupt Practices Act (FCPA) investigations and enforcement actions for 180 days. Attorney General Pam Bondi had signalled shifts in the DOJ's priorities towards the goal of "total elimination" of drug cartels and Transnational Crime Organizations (TCOs). Several of the Attorney General's memoranda at the time also alluded to potential deprioritisation of corporate enforcement in business-related national security cases and protection of US companies in particular. On the basis of these broad strokes directions, the DOJ had been directed to issue new guidelines.